Issue 1/2009
VIII Madrid Breast Cancer Conference: Latest Advances in Breast Cancer
Content (19 Articles)
Are we HER-ting for innovation in neoadjuvant breast cancer trial design?
Natasa Snoj, Philippe L Bedard, Evandro de Azambuja, Fatima Cardoso, Martine Piccart
CD146 expression is associated with a poor prognosis in human breast tumors and with enhanced motility in breast cancer cell lines
Gwladys Zabouo, Anne-Marie Imbert, Jocelyne Jacquemier, Pascal Finetti, Thomas Moreau, Benjamin Esterni, Daniel Birnbaum, François Bertucci, Christian Chabannon
Erratum to: Breast cancer proteomics reveals correlation between estrogen receptor status and differential phosphorylation of PGRMC1
Hans Neubauer, Susan E Clare, Wojciech Wozny, Gerhard P Schwall, Slobodan Poznanovic, Werner Stegmann, Ulrich Vogel, Karl Sotlar, Diethelm Wallwiener, Raffael Kurek, Tanja Fehm, Michael A Cahill
Phosphoinositide 3-kinase targeting by the β galactoside binding protein cytokine negates akt gene expression and leads aggressive breast cancer cells to apoptotic death
Valerie Wells, Livio Mallucci
Novel multicellular organotypic models of normal and malignant breast: tools for dissecting the role of the microenvironment in breast cancer progression
Deborah L Holliday, Kellie T Brouilette, Anja Markert, Linda A Gordon, J Louise Jones
Do Asian breast cancer patients have poorer survival than their western counterparts? A comparison between Singapore and Stockholm
Benita Kiat Tee Tan, Gek Hsiang Lim, Kamila Czene, Per Hall, Kee Seng Chia
Tamoxifen induces pleiotrophic changes in mammary stroma resulting in extracellular matrix that suppresses transformed phenotypes
Rhonda Hattar, Ori Maller, Shauntae McDaniel, Kirk C Hansen, Karla J Hedman, Traci R Lyons, Scott Lucia, R Storey Wilson Jr, Pepper Schedin
Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer
Günther Weber, Clara Ibel Chamorro, Fredrik Granath, Annelie Liljegren, Sami Zreika, Zuzana Saidak, Bengt Sandstedt, Samuel Rotstein, Romuald Mentaverri, Fabio Sánchez, Andor Pivarcsi, Mona Ståhle
Gene expression profiling of the tumor microenvironment during breast cancer progression
Xiao-Jun Ma, Sonika Dahiya, Elizabeth Richardson, Mark Erlander, Dennis C Sgroi
A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2genes based on cancer family history
Encarna B Gómez García, Jan C Oosterwijk, Maarten Timmermans, Christi J van Asperen, Frans BL Hogervorst, Nicoline Hoogerbrugge, Rogier Oldenburg, Senno Verhoef, Charlotte J Dommering, Margreet GEM Ausems, Theo AM van Os, Annemarie H van der Hout, Marjolijn Ligtenberg, Ans van den Ouweland, Rob B van der Luijt, Juul T Wijnen, Jan JP Gille, Patrick J Lindsey, Peter Devilee, Marinus J Blok, Maaike PG Vreeswijk
Transforming growth factor-β in breast cancer: too much, too late
Mary Helen Barcellos-Hoff, Rosemary J Akhurst
Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the California Cancer Registry
Jason A Zell, Walter Y Tsang, Thomas H Taylor, Rita S Mehta, Hoda Anton-Culver
The transition from ductal carcinoma in situto invasive breast cancer: the other side of the coin
Stuart J Schnitt
Association between breast cancer susceptibility loci and mammographic density: the Multiethnic Cohort
Christy G Woolcott, Gertraud Maskarinec, Christopher A Haiman, Martijn Verheus, Ian S Pagano, Loïc Le Marchand, Brian E Henderson, Laurence N Kolonel
Determination of HER2 phosphorylation at tyrosine 1221/1222 improves prediction of poor survival for breast cancer patients with hormone receptor-positive tumors
Thomas Frogne, Anne-Vibeke Laenkholm, Maria B Lyng, Katrine Lütken Henriksen, Anne E Lykkesfeldt
Prediction of paclitaxel sensitivity by CDK1 and CDK2 activity in human breast cancer cells
Satoshi Nakayama, Yasuhiro Torikoshi, Takeshi Takahashi, Tomokazu Yoshida, Tamotsu Sudo, Tomoko Matsushima, Yuko Kawasaki, Aya Katayama, Keigo Gohda, Gabriel N Hortobagyi, Shinzaburo Noguchi, Toshiyuki Sakai, Hideki Ishihara, Naoto T Ueno
Protein kinase D1 regulates matrix metalloproteinase expression and inhibits breast cancer cell invasion
Tim Eiseler, Heike Döppler, Irene K Yan, Steve Goodison, Peter Storz
Breast tumor heterogeneity: causes and consequences
K Polyak, M Shipitsin, LL Campbell-Marrotta, N Bloushtain-Qimron, So Yeon Park
Methylation of homeobox genes is a frequent and early epigenetic event in breast cancer
Stella Tommasi, Deborah L Karm, Xiwei Wu, Yun Yen, Gerd P Pfeifer